About CereVasc
CereVasc is a company based in Auburndale (United States) founded in 2015 by Adel Malek, Patrick Sullivan, and Carl Heilman.. CereVasc has raised $113.9 million across 2 funding rounds from investors including Bain Capital, Xontogeny and ATON Partners. CereVasc offers products and services including eShunt System. CereVasc operates in a competitive market with competitors including IRRAS, Tissuemed, Longeviti, Aqueduct Critical Care and NeuroDx, among others.
- Headquarter Auburndale, United States
- Founders Adel Malek, Patrick Sullivan, Carl Heilman
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cerevasc, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$113.9 M (USD)
in 2 rounds
-
Latest Funding Round
$70 M (USD), Series B
May 13, 2024
-
Investors
Bain Capital
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CereVasc
CereVasc offers a comprehensive portfolio of products and services, including eShunt System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Minimally invasive device for treating hydrocephalus
Unlock access to complete
Funding Insights of CereVasc
CereVasc has successfully raised a total of $113.9M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $70 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $70.0M
-
First Round
First Round
(22 May 2020)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series B - CereVasc | Valuation | Bain Capital | |
| May, 2020 | Amount | Series A - CereVasc | Valuation | ATON Partners , Xontogeny |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CereVasc
CereVasc has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Bain Capital, Xontogeny and ATON Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science startups are accelerated through focused programs by Xontogeny.
|
Founded Year | Domain | Location | |
|
Debt and equity investments are pursued across multiple sectors.
|
Founded Year | Domain | Location | |
|
Management consulting and investment guidance in medical technology are provided by ATON Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CereVasc
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CereVasc
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cerevasc Comparisons
Competitors of CereVasc
CereVasc operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IRRAS, Tissuemed, Longeviti, Aqueduct Critical Care and NeuroDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of devices for fluid control and management after surgery
|
|
| domain | founded_year | HQ Location |
Bioadhesive films are developed to seal leaks in surgical procedures.
|
|
| domain | founded_year | HQ Location |
Implantable neurosurgical devices are developed for cranial defect correction.
|
|
| domain | founded_year | HQ Location |
Novel products to manage Cerebral Spinal Fluid (CSF) pressure
|
|
| domain | founded_year | HQ Location |
Medical devices for assessing shunt function in hydrocephalus patient.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cerevasc
Frequently Asked Questions about CereVasc
When was CereVasc founded?
CereVasc was founded in 2015 and raised its 1st funding round 5 years after it was founded.
Where is CereVasc located?
CereVasc is headquartered in Auburndale, United States. It is registered at Auburndale, Florida, United States.
Who is the current CEO of CereVasc?
Daniel Levangie is the current CEO of CereVasc.
Is CereVasc a funded company?
CereVasc is a funded company, having raised a total of $113.9M across 2 funding rounds to date. The company's 1st funding round was a Series A of $43.9M, raised on May 22, 2020.
What does CereVasc do?
CereVasc was founded in 2015 and is based in Auburndale, United States. The company operates in the medical device sector, focusing on neurological conditions. A non-invasive cerebrospinal fluid shunt and catheter-based delivery system are being developed to treat communicating hydrocephalus, which impacts children and adults. Operations center on advancing this eShunt solution for clinical use.
Who are the top competitors of CereVasc?
CereVasc's top competitors include Tissuemed, Aqueduct Critical Care and IRRAS.
What products or services does CereVasc offer?
CereVasc offers eShunt System.
Who are CereVasc's investors?
CereVasc has 3 investors. Key investors include Bain Capital, Xontogeny, and ATON Partners.